A Phase II Study to Evaluate the Safety and Efficacy of Defibrotide in Children with High Risk Kawasaki Disease (IND 127812)

Authors

Edo Schaefer, New York Medical College
Qiuhu Shi, New York Medical CollegeFollow
Karen Brandstaedter, New York Medical College
Kristina Melchert, New York Medical College
Darshan Patel, New York Medical College
Erin Morris
Sandra Fabricatore
Elizabeth Mintzer
John DuFresne
Kenneth R. Cooke
Mitchell S. Cairo, New York Medical CollegeFollow

Author Type(s)

Faculty

Document Type

Abstract

Publication Date

11-2-2023

DOI

10.1182/blood-2023-184832

Journal Title

Blood

Department

Pediatrics

Second Department

Public Health

Recommended Citation

Schaefer, E., Shi, Q., Brandstaedter, K., Melchert, K., Patel, D., Morris, E., Fabricatore, S., Mintzer, E., DuFresne, J., Cooke, K. R., & Cairo, M. S. (2023). A Phase II Study to Evaluate the Safety and Efficacy of Defibrotide in Children with High Risk Kawasaki Disease (IND 127812). Blood, 142 (Suppl. 1), 5412. https://doi.org/10.1182/blood-2023-184832